Investor Relations

Investor Relations

BioSig Technologies, Inc Corporate Summary

February 2024

View Corporate Summary

Latest Financial Results

Q3 2023

Quarter Ended Sep 30, 2023

Latest Annual Report

View Annual Report

Stock Information

Symbol

Nasdaq: BSGM

Price

Change

Volume

52 week Low/High

Day Low/High

Company Overview

BioSig Technologies is a medical device company commercializing a proprietary technology platform designed to improve the $8 billion electrophysiology (EP) marketplace. By 2028, the EP market is expected to reach $16 billion, with an estimated 11.2% CAGR.

Investor Relations

T: (203) 409-5444 x 133
info@biosigtech.com

Transfer Agent

Securities Transfer Corporation
2901 N. Dallas Parkway
Suite 380
Plano, TX 75093
T: (469) 633-0101
F: (469) 633-0088
info@stctransfer.com
www.stctransfer.com